Immunotech Laboratories's accounts payable is $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Immunotech Laboratories (IMMB) currently reports a accounts payable of $0 as of December 2016. Use the charts on this page to explore Immunotech Laboratories's accounts payable history and peer comparisons.
Immunotech Laboratories reported $0 in accounts payable as of December 2016. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunotech Laboratories, and consider following IMMB for alerts when major investors trade the stock.
Immunotech Laboratories is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMMB with unrelated industries.